Fact-checked by Grok 2 weeks ago

Inverse psoriasis

Inverse psoriasis, also known as flexural or intertriginous psoriasis, is a variant of plaque psoriasis that manifests as smooth, shiny, erythematous patches in the skin folds of the body, such as the armpits, groin, inframammary region, and anogenital area.^[1] Unlike typical plaque psoriasis, it features minimal or absent scaling due to the moist environment of these areas, often presenting with itching, soreness, and a glossy appearance that may appear purplish, brown, or darker on skin of color and bright red on lighter skin tones.^[2] This condition arises from an immune-mediated inflammatory process similar to other forms of psoriasis, where overactive T cells trigger rapid skin cell proliferation, leading to the characteristic lesions.^[3] The prevalence of inverse psoriasis among individuals with psoriasis varies widely, estimated at 3% to 36%, influenced by diagnostic criteria and whether genital involvement is included, though it commonly affects 21% to 30% of psoriasis patients, particularly those who are overweight or have deep skin folds.^[1] It can occur at any age, including as napkin psoriasis in infants, and may be triggered by factors such as friction, infections (including fungal or bacterial colonization in moist areas), stress, tobacco use, alcohol, or certain medications.^[2] Diagnosis is primarily clinical, based on the location and appearance of lesions, with dermoscopy revealing distinctive "bushy" capillary patterns to differentiate it from similar conditions like intertrigo, candidiasis, or tinea infections; a skin biopsy may be performed if uncertainty exists.^[1] The condition often impacts quality of life due to pain, embarrassment, and potential secondary infections in the occluded areas, and it shares the chronic, relapsing nature of psoriasis with risks for comorbidities such as psoriatic arthritis, cardiovascular disease, and depression.^[3] Treatment focuses on reducing inflammation and managing symptoms, as there is no cure, with first-line options including low- to mid-potency topical corticosteroids (e.g., betamethasone, achieving up to 86% improvement in severity scores), calcineurin inhibitors (e.g., tacrolimus), and vitamin D analogs (e.g., calcipotriol).^[1] For more severe or widespread cases, systemic therapies such as methotrexate, cyclosporine, or biologics (e.g., ixekizumab, clearing up to 73% of genital lesions) may be employed, alongside supportive measures like emollients, antifungal agents for superinfections, and keeping the skin dry with powders to prevent maceration.^[2] Phototherapy can be useful but requires caution in fold areas to avoid Koebnerization, and lifestyle modifications—such as weight management and trigger avoidance—play a key role in long-term control.^[3]

Definition and Characteristics

Definition

Inverse psoriasis is an immune-mediated inflammatory skin condition classified as a subtype of psoriasis, characterized by the development of smooth, shiny, erythematous plaques in flexural or intertriginous areas where skin folds occur, such as the armpits, groin, inframammary folds, and gluteal cleft.^[1] Unlike typical plaque psoriasis, these lesions lack the thick, silvery scales commonly seen elsewhere on the body, as the moisture and friction in skin folds prevent scale formation.^[3] This variant is also referred to as flexural psoriasis due to its preferential involvement of body creases.^[4] The appearance of inverse psoriasis lesions can vary by skin tone; on lighter skin, they present as bright red and glossy patches, while on skin of color, they may appear violaceous, brown, or hyperpigmented relative to surrounding areas.^[2] These plaques are often well-demarcated and may be accompanied by fissuring in deeper folds, contributing to discomfort in affected regions.^[1]

Distinction from Other Psoriasis Types

Inverse psoriasis, also known as flexural psoriasis, primarily affects skin folds such as the armpits, groin, and inframammary regions, presenting as smooth, erythematous patches without the thick, silvery scales characteristic of plaque psoriasis, which typically occurs on extensor surfaces like the elbows and knees.^[5]^[6] The absence of scaling in inverse psoriasis results from the moist environment and friction in intertriginous areas, making lesions appear smoother and more prone to secondary bacterial or fungal infections compared to the drier, scaly plaques of the more common plaque variant, which accounts for 80-90% of cases.^[7]^[8] Unlike guttate psoriasis, which manifests as numerous small, drop-shaped lesions often triggered by streptococcal infections and appearing acutely on the trunk, inverse psoriasis is chronic and not associated with such infectious precipitants, instead exacerbated by heat, sweat, or trauma in flexural sites.^[5]^[6] In contrast to pustular psoriasis, which features sterile pustules either localized to palms and soles or widespread in severe forms, or erythrodermic psoriasis involving over 90% of the body surface with intense erythema and exfoliation, inverse psoriasis remains confined to skin folds without pustule formation or systemic exfoliative involvement.^[5]^[8] Although all psoriasis variants share an underlying autoimmune mechanism involving T-cell mediated inflammation, up to 21-30% of individuals with psoriasis may develop inverse lesions alongside other forms like plaque, with the intertriginous distribution serving as a key distinguishing feature in mixed presentations.^[2]^[9]

Clinical Presentation

Signs and Symptoms

Inverse psoriasis manifests as well-demarcated, erythematous plaques that appear smooth and shiny, with minimal to no scaling due to the moist environment of affected skin folds.^[2]^[1] These lesions often exhibit superficial erosions, fissuring, or maceration, contributing to a glossy, inflamed appearance.^[1] Patients commonly experience primary symptoms of intense itching, soreness, and a burning sensation, which can significantly impact daily comfort.^[2]^[4] These sensations are frequently exacerbated by sweating and friction, as the occluded areas trap moisture and promote irritation.^[2]^[1]^[4] Lesion appearance varies by skin tone: on lighter skin, the plaques typically present as bright red, while on darker skin tones, they may appear purple-brown or darker than the surrounding skin.^[2] Secondary bacterial or fungal infections, common in these moist sites, can lead to white scaling overlying the inflamed areas.^[1] Symptom severity is generally mild to moderate, including pain that is particularly noticeable in regions such as the groin or under the breasts, and it often intensifies with factors like obesity or heat, which increase friction and perspiration.^[4]^[2]

Epidemiology and Risk Factors

The prevalence of inverse psoriasis among individuals with psoriasis varies from 3% to 36%, commonly estimated at 21% to 30%.^[1]^[2] This subtype is more prevalent among individuals who are overweight or obese, as excess body weight can exacerbate skin fold involvement, with studies indicating that a body mass index (BMI) greater than 30 is associated with approximately a 1.5- to 2.7-fold increased risk of developing psoriasis, including inverse forms.^[10]^[2] Onset typically occurs in adulthood, most commonly between the ages of 20 and 40 years, though it can appear at any age.^[2] The condition is often underdiagnosed in individuals with skin of color, where lesions may present with less scaling and more erythema or hyperpigmentation, leading to misattribution to other flexural dermatoses.^[11]^[12] A family history of psoriasis substantially elevates risk, with first-degree relatives of affected individuals facing up to a 10-fold higher likelihood of developing the condition compared to the general population.^[13] Inverse psoriasis, like other forms, is linked to several associated conditions, including metabolic syndrome, type 2 diabetes mellitus, and cardiovascular disease, reflecting shared inflammatory pathways that increase comorbidity prevalence by 1.5- to 2-fold in affected patients.^[14]^[15]^[16] Obesity is associated with increased incidence of psoriasis, including inverse forms, amid the ongoing obesity epidemic.^[10]

Pathophysiology

Genetic and Immune Mechanisms

Inverse psoriasis shares a genetic foundation with other psoriasis subtypes, characterized by polygenic inheritance involving more than 80 susceptibility loci identified through genome-wide association studies (GWAS).^[17] These loci collectively contribute to disease risk, with the major histocompatibility complex (MHC) region, particularly the PSORS1 locus, accounting for the largest heritability fraction, estimated at 35-50%.^[18] The HLA-Cw6 allele within PSORS1 is the strongest individual risk factor, associated with psoriasis susceptibility in approximately 50% of cases across populations, and linked to earlier onset and more severe manifestations. Although specific prevalence data for inverse psoriasis are limited, this allele's role underscores the shared genetic architecture with plaque psoriasis.^[19] Immune dysregulation in inverse psoriasis centers on T-cell-mediated inflammation, where autoreactive CD4+ and CD8+ T cells infiltrate the skin and drive chronic immune activation.^[20] Key cytokines, including interleukin-17 (IL-17), IL-23, and tumor necrosis factor-alpha (TNF-α), are overproduced by Th17 cells and dendritic cells, amplifying the inflammatory cascade.^[21] IL-23 promotes Th17 differentiation and IL-17 secretion, which synergizes with TNF-α to induce keratinocyte proliferation and chemokine release, sustaining the cycle of inflammation.^[22] This dysregulation leads to epidermal hyperproliferation, manifesting as acanthosis—thickening of the spinous layer—without the pronounced hyperkeratosis typical of plaque psoriasis, owing to the moist flexural environment that limits scale formation.^[23] Pathologically, inverse psoriasis exhibits spongiosis, characterized by intercellular edema in the epidermis, alongside a thinned or reduced stratum corneum due to frictional moisture in intertriginous areas.^[24] These features reflect barrier disruption mediated by innate immune responses, including activation of plasmacytoid dendritic cells and release of antimicrobial peptides like cathelicidin, which exacerbate local inflammation.^[25] Neutrophilic infiltration in the dermis and scale is common, further contributing to the erythematous, erosive lesions observed.^[26] Recent 2025 GWAS meta-analyses have advanced understanding by identifying novel susceptibility loci for psoriasis and confirming polygenic risk contributions, though inverse-specific variants remain under investigation. These studies emphasize the IL-23/Th17 axis as a convergent therapeutic target across variants.^[27]^[28]

Environmental Triggers

Inverse psoriasis, affecting skin folds such as the armpits, groin, and inframammary regions, is particularly susceptible to exacerbation by environmental factors that promote irritation and microbial growth in occluded areas. Friction from skin-to-skin rubbing, often intensified in individuals with deeper folds, leads to intertrigo-like irritation and can precipitate flares. ^[1] Moisture accumulation due to occlusion in these areas fosters maceration and superficial erosions, while sweating—exacerbated by hyperhidrosis or humid environments—further aggravates soreness and itching. ^[1] ^[2] Lifestyle elements play a significant role in triggering or worsening inverse psoriasis. Obesity increases mechanical pressure on skin folds, promoting friction and moisture retention, which heightens the risk of onset and severity; studies indicate a twofold increased risk of psoriasis in obese individuals compared to those of normal weight. ^[29] ^[2] Tight clothing, synthetic fabrics, or wool can trap heat and moisture, while hot climates amplify sweating and irritation in affected areas. ^[1] Infections and irritants are common precipitants, especially in the warm, moist milieu of skin folds. Candida overgrowth thrives in these conditions, leading to secondary superinfections that mimic or trigger inverse psoriasis flares, though the exact role of microbial colonization remains debated. ^[1] Irritants such as soaps, latex, or other allergens can provoke inflammation upon contact with sensitive flexural skin. ^[2] Additional factors include stress, which may indirectly heighten immune responses to these environmental insults, and smoking, associated with a 1.5- to 2-fold increased risk of psoriasis development and flares through inflammatory mechanisms. ^[2] ^[30] Hormonal changes in women, such as those during puberty, pregnancy, or menopause, can fluctuate disease severity, potentially worsening symptoms in inverse psoriasis. ^[31]

Diagnosis

Clinical Assessment

The clinical assessment of inverse psoriasis begins with a detailed patient history to identify key risk factors and symptom patterns. Clinicians inquire about family history of psoriasis, as genetic predisposition plays a significant role in its development.^[3] The duration of symptoms is evaluated, along with aggravating factors such as friction from skin folds, sweating, infections, stress, or skin injuries that may exacerbate lesions.^[2] During the physical examination, the dermatologist inspects the affected areas, focusing on flexural sites like the axillae, groin, inframammary folds, and intergluteal cleft for characteristic smooth, well-demarcated, erythematous plaques that lack scaling due to the moist environment.^[32] Palpation assesses for tenderness or pain in these regions, and variations in skin tone are noted, with lesions appearing bright red on lighter skin or purple-ish, brown, or darker on skin of color.^[2] Diagnosis relies on clinical pattern recognition, as there are no specific diagnostic criteria unique to inverse psoriasis; instead, the presentation in intertriginous areas guides identification.^[32] The Psoriasis Area and Severity Index (PASI) may be adapted to assess severity, though modifications account for the absence of desquamation in these lesions.^[33] Symptom overlap with conditions like intertrigo can occur, necessitating careful differentiation through history and exam.^[2] According to American Academy of Dermatology (AAD) guidelines, dermatologists play a crucial role in early recognition of inverse psoriasis to mitigate complications such as secondary infections in occluded areas.^[34]

Differential Diagnosis and Tests

Inverse psoriasis, characterized by smooth, erythematous plaques in flexural areas, must be differentiated from other conditions that cause similar intertriginous eruptions, including intertrigo due to mechanical friction, fungal infections such as candidiasis or tinea cruris, bacterial infections like erythrasma, seborrheic dermatitis, contact dermatitis, and hidradenitis suppurativa.^[1]^[35]^[36] Less common mimics include lichen planus, atopic dermatitis, and Zoon's plasma cell mucositis.^[1] Diagnostic confirmation often requires targeted tests to exclude infections and confirm psoriatic changes, as clinical overlap with these entities can lead to frequent misdiagnosis, particularly in isolated flexural lesions; one study reported initial misdiagnosis in up to 40% of cases with exclusive flexural involvement, often attributed to infectious intertrigo.^[1]^[36] Dermoscopy may aid differentiation by revealing distinctive "bushy" capillary patterns and red dots.^[1] A potassium hydroxide (KOH) preparation of skin scrapings is commonly performed to rule out fungal elements like yeast or hyphae in suspected candidiasis or dermatophytosis.^[35]^[1] Swab cultures for bacterial or fungal pathogens are recommended if secondary infection is suspected, helping to identify organisms such as Corynebacterium in erythrasma.^[1] Skin biopsy is reserved for atypical or refractory cases but provides definitive evidence through histopathology revealing psoriasiform dermatitis with epidermal hyperplasia, elongated rete ridges, parakeratosis, thinned suprapapillary plates, and occasional Munro microabscesses.^[1] Direct immunofluorescence is rarely needed unless autoimmune blistering disorders are considered in the differential.^[1] Routine blood tests or imaging are not indicated unless systemic involvement or complications like psoriatic arthritis are suspected, though baseline labs may be obtained prior to initiating therapies.^[3]

Management and Treatment

Topical and Localized Therapies

Topical therapies form the cornerstone of management for inverse psoriasis, particularly given the location in flexural areas where the skin is thin, moist, and prone to irritation from stronger agents. These treatments aim to reduce inflammation, alleviate symptoms like itching and soreness, and prevent secondary infections without causing atrophy or other adverse effects common in occluded regions. Low-potency formulations are preferred to minimize risks, with application typically limited to short durations and monitored closely.^[37]^[38] Corticosteroids remain a first-line option for mild to moderate inverse psoriasis, with low-potency agents such as hydrocortisone 1% or mid-potency options like fluticasone propionate 0.005% recommended for sensitive intertriginous sites to curb inflammation effectively while reducing the risk of skin thinning. These are applied once or twice daily for 2 to 4 weeks, followed by tapering to avoid side effects like telangiectasia or striae, which are heightened in flexural areas due to occlusion. Clinical evidence indicates that such regimens achieve over 50% improvement in lesion severity, with higher-potency variants like betamethasone 0.1% reserved for refractory cases, yielding up to 86% reduction in modified Psoriasis Area and Severity Index (m-PASI) scores in targeted studies.^[37]^[38] Calcineurin inhibitors, including tacrolimus 0.1% ointment and pimecrolimus 1% cream, serve as effective steroid-sparing alternatives, particularly for long-term maintenance in facial or genital involvement where atrophy from corticosteroids is a concern. These non-steroidal topicals inhibit T-cell activation to dampen immune responses, demonstrating clearance or significant improvement in 65% to 71% of patients across trials focused on inverse and intertriginous psoriasis. Applied twice daily, they may initially cause transient burning or pruritus but offer a favorable safety profile for extended use in moist folds.^[38]^[39] Additional topical agents complement these core treatments, tailored to specific needs in inverse psoriasis. Vitamin D analogs such as calcipotriene or calcitriol ointment slow keratinocyte proliferation and are suitable for flexural areas, with calcitriol showing 67% efficacy in clearance rates compared to 33% for calcipotriol in sensitive sites; they are often combined with low-potency corticosteroids for enhanced results. Coal tar preparations, while versatile for psoriasis, require dilution with a moisturizer to prevent irritation in skin folds and are applied sparingly to reduce scaling. Antifungals like clotrimazole are incorporated if secondary candidal infections arise, common in occluded areas, to address both psoriasis and microbial overgrowth. Moisture barriers, including zinc oxide pastes or absorbent powders, help maintain dryness in intertriginous zones, thereby reducing friction and infection risk.^[38]^[2]^[40] As of 2025, novel non-steroidal topicals like tapinarof 1% cream, an aryl hydrocarbon receptor agonist, have gained traction for inverse psoriasis due to its once-daily application, anti-inflammatory effects, and suitability for sensitive areas without steroid-related risks. Approved initially for plaque psoriasis, it has demonstrated safety and efficacy in flexural involvement, providing sustained remission and itch relief in clinical use.^[41]^[42]

Systemic and Advanced Therapies

For moderate-to-severe inverse psoriasis that does not respond adequately to topical therapies, systemic treatments are employed to address widespread inflammation and immune dysregulation. Oral medications such as methotrexate, administered at doses of 7.5 to 25 mg weekly, have demonstrated efficacy in controlling severe cases by suppressing immune activity and reducing lesion severity.^[43] Cyclosporine is utilized for short-term management in acute flares, typically at 3 to 5 mg/kg daily, offering rapid clearance but limited to 3 to 6 months due to potential renal toxicity.^[38] Acitretin, an oral retinoid dosed at 25 to 50 mg daily, is particularly beneficial in cases with hyperkeratotic features overlapping inverse psoriasis, as it normalizes keratinization and enhances skin barrier function.^[44] Biologic therapies targeting key cytokines provide high efficacy for refractory inverse psoriasis, especially in flexural areas. Interleukin-17 (IL-17) inhibitors, including secukinumab (300 mg subcutaneously every 4 weeks after loading) and ixekizumab (160 mg loading dose followed by 80 mg every 4 weeks), achieve significant improvement in 70-80% of patients with genital and inverse involvement, with ixekizumab yielding 73% clear or almost clear static Physician Global Assessment (sPGA) scores for genital skin at week 12.^[38] Interleukin-23 (IL-23) inhibitors like guselkumab (100 mg subcutaneously at weeks 0 and 4, then every 8 weeks) offer sustained responses, with real-world data showing progressive effectiveness over time in inverse psoriasis cohorts, though with a slightly slower onset compared to IL-17 agents.^[45] Overall, these biologics report response rates of 80-90% in flexural psoriasis subsets, prioritizing patient tolerability in sensitive areas.^[46] Phototherapy serves as a non-pharmacologic systemic option, with narrowband ultraviolet B (NB-UVB) adapted for intertriginous sites by using lower doses (initially 0.1-0.3 J/cm², escalating cautiously) to minimize irritation in moist folds while achieving clearance in 60-80% of cases after 20-30 sessions.^[47] The excimer laser (308 nm) enables targeted delivery to localized flexural plaques, delivering higher fluence (up to 16 J/cm²) with fewer sessions (8-12) and reduced risk of adjacent skin exposure, proving effective for resistant lesions.^[48] As of 2025, Janus kinase (JAK) inhibitors represent emerging options for refractory inverse psoriasis. Deucravacitinib, an oral TYK2 inhibitor dosed at 6 mg daily, has shown successful clearance in case reports of inverse psoriasis unresponsive to prior therapies, with sustained remission over 12 months and a favorable safety profile.^[49]

Prognosis and Complications

Disease Course and Outlook

Inverse psoriasis follows a chronic relapsing course, characterized by periods of flare-ups interspersed with remission phases that can last for months or years. Flares are often triggered by factors such as weight gain, which exacerbates skin fold friction, and infections, including streptococcal or fungal overgrowth in affected areas.^[50]^[3] Remission is achievable and more sustained with consistent treatment adherence, including topical therapies and lifestyle modifications to minimize triggers.^[2]^[51] Prognostic factors include body weight, with non-obese patients experiencing better disease control and response to therapies due to reduced intertriginous irritation and improved drug efficacy. Combined therapies, such as biologics with topicals, can enable significant improvement in skin clearance for many patients with moderate-to-severe psoriasis.^[52] Regular dermatology follow-ups are essential for monitoring disease activity, adjusting treatments, and preventing complications from untreated flares.^[3] The condition significantly impacts quality of life, with genital involvement—a common feature of inverse psoriasis—leading to discomfort, embarrassment, and sexual health challenges such as avoidance of intimacy or pain during activity. As of 2025, emerging evidence suggests that early initiation of biologics may alter the disease course, leading to improved long-term outcomes and higher rates of skin clearance.^[53]

Associated Risks and Prevention

Inverse psoriasis, due to its location in skin folds, carries risks of secondary infections from bacteria or fungi thriving in moist environments. These infections, such as candidiasis or dermatophytosis, can manifest as pus-filled bumps, swelling, or foul odor, and may progress to more serious conditions like cellulitis if untreated.^[3]^[1] In severe cases, persistent scratching or fissuring can lead to delayed healing and potential scarring, though psoriasis itself rarely causes permanent scars.^[54] Additionally, individuals with psoriasis, including the inverse subtype, face an elevated risk of Crohn's disease, with meta-analyses reporting a risk ratio of 2.53 (95% CI, 1.65-3.89) for Crohn's disease compared to the general population.^[55] Individuals with inverse psoriasis, like those with other psoriasis subtypes, have an elevated risk of developing psoriatic arthritis. Preventive strategies focus on minimizing moisture, friction, and triggers to reduce flare frequency and infection risk. Weight management is key, as obesity exacerbates symptoms in flexural areas; studies show that a 5-10% body weight reduction can decrease psoriasis severity and improve treatment response.^[56]^[57] Wearing loose, breathable clothing made from cotton or moisture-wicking fabrics helps prevent irritation and sweat accumulation in affected areas.^[3] Gentle hygiene practices are essential: bathe daily in lukewarm water using mild, fragrance-free soaps to avoid drying out or irritating sensitive skin, then pat dry thoroughly and apply moisturizers or absorbent powders to keep folds dry.^[3]^[58] Lifestyle modifications include stress reduction through mindfulness or exercise, as stress can trigger flares, and smoking cessation, which lowers overall psoriasis exacerbation risk.^[59]^[2] In humid climates, where moisture promotes fungal overgrowth, prophylactic antifungal agents may be recommended for those prone to recurrent infections, as emphasized in recent dermatology updates highlighting intertriginous vulnerability.^[1]^[2]

References

[1]
Inverse Psoriasis: From Diagnosis to Current Treatment Options - NIH
Inverse psoriasis (IP), also known as flexural or intertriginous psoriasis, is a variety of plaque psoriasis that involves the body folds.
[2]
Inverse Psoriasis: Symptoms, Causes & Treatment
Mar 26, 2025 · Inverse psoriasis appears on skin of color as lesions of purple-ish, brown, or darker than the surrounding skin, in body folds.Symptoms · Causes & Triggers · Treatment & Management
[3]
Inverse Psoriasis: What It Is, Treatment, Groin & Armpit
Apr 25, 2022 · Inverse psoriasis is an immune-mediated condition. It causes a rash in areas of your skin that rub together, including your groin and armpits.Overview · Symptoms And Causes · Management And Treatment
[4]
Psoriasis - Symptoms and causes - Mayo Clinic
Feb 21, 2025 · Inverse psoriasis causes smooth patches of inflamed skin in the folds of the skin. It usually appears under the breasts and around the groin ...
[5]
Inverse Psoriasis - Verywell Health
Jul 6, 2025 · Inverse psoriasis is an autoimmune condition that causes itchy, smooth lesions in places where your skin rubs together, like the armpits, groin, and under the ...Missing: definition | Show results with:definition<|control11|><|separator|>
[6]
Inverse Psoriasis (Flexural Psoriasis): Symptoms and Treatment
Oct 4, 2024 · Inverse psoriasis is a condition that affects folds of skin. Skin cells multiply too quickly, and a rash forms in places like your armpits and groin where ...Inverse Psoriasis Symptoms · Inverse Psoriasis Diagnosis · Inverse Psoriasis...Missing: definition | Show results with:definition
[7]
Psoriasis - StatPearls - NCBI Bookshelf - NIH
Psoriasis can present with different morphology in the form of plaque, guttate, rupioid, erythrodermic, pustular, inverse, elephantine, and psoriatic arthritis.
[8]
Psoriasis - AAFP
May 1, 2013 · The prevalence ranges from 6 to 42 percent of patients with psoriasis, with men and women equally affected. The Classification Criteria for ...
[9]
Types of Psoriasis
Jun 24, 2025 · Signs of inverse psoriasis include inflamed deep-red or darkened skin that is smooth and not scaly. Inverse psoriasis affects skin folds in the ...
[10]
Psoriasis: What It Is, Symptoms, Causes, Types & Treatment
Inverse psoriasis: This type appears in your skin folds. It causes thin plaques without scales. Guttate psoriasis: Guttate psoriasis may appear after a sore ...Inverse Psoriasis · Psoriasis Treatment · Plaque Psoriasis · Scalp Psoriasis<|control11|><|separator|>
[11]
Types of psoriasis: Can you have more than one?
Inverse psoriasis only forms in areas where skin touches skin, such as the armpits, groin, or underneath the breasts. It causes smooth, bright-red patches of ...
[12]
Prevalence of inverse psoriasis subtype with immune checkpoint ...
The prevalence of inverse psoriasis varies between 3% and 7% among patients with any diagnosis of psoriasis, outside the immune-checkpoint inhibitors (ICI)- ...
[13]
Obesity, Waist Circumference, Weight Change, and the Risk of ...
In our cohort, 30% of the incident psoriasis cases were attributable to a BMI of 25.0 or greater (overweight). ... risk of incident psoriasis among obese ...
[14]
How Psoriasis Is Different in Women - Everyday Health
Inverse psoriasis usually occurs in body folds such as the underarms, under breasts, and in the genital area. Symptoms include skin that looks smooth, glossy, ...
[15]
Special Considerations in the Diagnosis and Treatment of Psoriasis
However, psoriasis in skin of color (SOC) populations often differs from this presentation, and is one reason that psoriasis may be underdiagnosed in these ...
[16]
Psoriasis in People of Color: Often Undiagnosed and Untreated
Oct 12, 2025 · People of color are often undiagnosed and undertreated for psoriasis. Find out why and what's being done to solve the problem.What Does Psoriasis Look... · Disparities In Diagnosis · Treatment DifferencesMissing: underdiagnosed | Show results with:underdiagnosed
[17]
Is Psoriasis Genetic?
Oct 29, 2025 · If neither parent has psoriasis, the chance of developing it is around 4% If one parent has psoriasis, your risk increases to about 14-28%Missing: inverse | Show results with:inverse
[18]
Cardiovascular and Metabolic Diseases Comorbid with Psoriasis
The association of psoriasis with metabolic syndrome (obesity, glucose intolerance, hypertension and dyslipidemia) has also been well documented (48, 49). As ...
[19]
Diabetes and Psoriasis: Different Sides of the Same Prism - PMC
Oct 7, 2020 · Psoriasis has been associated with other chronic diseases including cardiometabolic disease (eg, DM, major adverse cardiovascular events ...
[20]
Cardiovascular comorbidities in psoriasis (Review)
Dec 17, 2021 · It has been shown that psoriasis is an independent cardiovascular risk factor, with patients developing ischemic heart disease/acute coronary syndrome, ...
[21]
Obesity Increases the Complexity of Plaque Psoriasis Treatment
May 26, 2025 · Obesity is linked not only with the risk of developing plaque psoriasis, it also can complicate treatment of the condition, which is more ...
[22]
Psoriasis: An Immunogenetic Perspective - PMC
To date, >70 psoriasis susceptibility loci have been identified, including HLA-Cw6, IL12B, IL23R, and LCE3B/3C. Some genetic markers are used in clinical ...
[23]
The current landscape of psoriasis genetics in 2020 - ScienceDirect
Of these loci, PSORS1 is known to be the major determinant of psoriasis susceptibility; it is in the MHC region, it explains about 35 %–50 % of the heritability ...
[24]
A partitioned 88-loci psoriasis genetic risk score reveals HLA and ...
May 30, 2023 · We found that both GRS-ALL and GRS-HLA were significantly associated with early age of psoriasis onset, psoriasis severity, first presentation of psoriasis at ...
[25]
Signaling pathways and targeted therapies for psoriasis - Nature
Nov 27, 2023 · Furthermore, IL-17 acts synergistically with TNF-α to stimulate keratinocytes to produce inflammatory cytokines and chemokines to recruit more ...Introduction · Signaling Pathways Driving... · The Tnf/il-23/il-17 Pathway
[26]
The Role of Interleukin 23/17 Axis in Psoriasis Management - NIH
Apr 10, 2024 · The IL-23/IL-17 axis in psoriasis has been a real breakthrough especially for patients who are non-responders to conventional treatments and/or ...
[27]
Psoriasis pathogenesis and the development of novel targeted ...
In response to IL-23, pathogenic T17 cells produce high levels of IL-17, which has broad inflammatory effects on keratinocytes and a variety of immune cells ...Cutaneous Lymphocyte Antigen... · Psoriasis Autoantigens · Il-17 Inhibition<|separator|>
[28]
Histopathologic features of inverse psoriasis - Wiley Online Library
Oct 6, 2021 · Regular psoriasiform acanthosis and dilated tortuous dermal vessels were seen in 92%. Neutrophils were present in the scale in 83% and in the ...
[29]
Histopathologic features of inverse psoriasis - PubMed
Regular psoriasiform acanthosis and dilated tortuous dermal vessels were seen in 92%. Neutrophils were present in the scale in 83% and in the dermis in 100%.
[30]
Cytokines in psoriasis - PMC - PubMed Central - NIH
This hyperproliferation is driven by cytokines secreted by activated resident immune cells, an infiltrate of T cells, dendritic cells and cells of the innate ...
[31]
Histopathologic features of inverse psoriasis - ResearchGate
Histologically, inverse psoriasis demonstrates epidermal acanthosis, diminished or absent parakeratosis, and a dense dermal inflammatory infiltrate ...
[32]
Multi-ancestry genome-wide meta-analysis with 472819 individuals ...
Jan 30, 2025 · We identified 74 genome-wide significant loci for psoriasis. Of 74 loci, 32 were novel psoriasis risk loci. Across 74 loci, 801 likely causal genes are ...<|control11|><|separator|>
[33]
GWAS meta-analysis of psoriasis identifies new susceptibility alleles ...
Feb 28, 2025 · The current study establishes two new psoriasis susceptibility loci harbouring genes encoding therapeutic targets (Table 1, Supplementary Data ...Missing: inheritance | Show results with:inheritance
[34]
Environmental Risk Factors in Psoriasis: The Point of View of the ...
Jul 22, 2016 · The aim of this review is to assess the relevance of the environmental factors as modifiable risk factors in psoriasis pathogenesis.
[35]
Triggers for the onset and recurrence of psoriasis: a review and update
Feb 12, 2024 · When stimulated by triggering events, DCs and Langerhans cells secrete IL-23, which interacts with IL-23R on the surface of TRM, particularly IL ...
[36]
Psoriasis: Female Skin Changes in Various Hormonal Stages ... - NIH
The age at onset was documented by Swanbeck et al. to begin around puberty as well as between the ages of 30 and 50 [19]. This bimodal age at onset has also ...
[37]
Psoriasis Clinical Presentation: History, Physical Examination ...
Jul 2, 2024 · Contributed by Randy Park, MD. Inverse psoriasis occurs on the flexural surfaces, armpit, groin, under the breast, and in the skin folds.History · Physical Examination · Ocular Manifestations
[38]
Psoriasis Area and Severity Index (PASI) score among inverse ...
There were statistically significant reductions in all PASI score items in inverse psoriasis cases after treatment (Table 2). There were statistically ...
[39]
Psoriasis clinical guideline - American Academy of Dermatology
The guideline is based on current evidence, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients.
[40]
Flexural psoriasis. Psoriasis in skin folds and genitals - DermNet
Flexural psoriasis is sometimes called inverse psoriasis and describes psoriasis localised to the skin folds and genitals.
[41]
Psoriasis: Practice Essentials, Background, Pathophysiology
Jul 2, 2024 · According to the National Institutes of Health (NIH), approximately 2.2% of the United States population has psoriasis. Internationally, the ...
[42]
Psoriasis: an update on topical and systemic therapies - PMC
Jun 10, 2025 · The physician-diagnosed prevalence of psoriasis in adults in Australia is estimated at around 2.4%. Psoriasis can have a large impact on ...Missing: inverse | Show results with:inverse
[43]
Psoriasis - Diagnosis and treatment - Mayo Clinic
Feb 21, 2025 · Mild corticosteroid ointments (hydrocortisone) are usually recommended for sensitive areas, such as the face or skin folds, and for treating ...
[44]
Genital and Inverse/Intertriginous Psoriasis: An Updated Review of ...
A score of 0 (clear) indicates that there is residual or no erythema, no plaque elevation, and no scaling. A score of 1–2 (minimal-to-mild) indicates a faint, ...
[45]
Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment ...
Mar 14, 2023 · In conclusion, topical calcineurin inhibitors appear to be effective and safe treatment options for facial and genital psoriasis with few local ...
[46]
How to Spot and Treat Inverse Psoriasis - Everyday Health
Roflumilast (Zoryve) and Tapinarof (Vtama) Creams These steroid-free topical medications suppress the immune system, reduce inflammation, and are safe to use ...
[47]
VTAMA® (tapinarof) cream, 1%
In the 12-week clinical studies, up to 40% of adult patients achieved clear or almost clear skin compared to 6% on cream with no active ingredient.Plaque Psoriasis · For Eczema · MyVTAMA™ Savings Card<|separator|>
[48]
The possibilities and principles of methotrexate treatment of psoriasis
The current recommended dose of MTX is 7.5–25 mg/week. The preferred dosage regimen is once weekly in three divided doses at 12 h intervals (so-called ...
[49]
Overview: Acitretin for Psoriasis - HMP Global Learning Network
Acitretin's ability to regulate keratinization makes acitretin useful for reducing scale in hyperkeratotic psoriasis and making phototherapy more effective.
[50]
Study Compares Benefits of Treating Inverse Psoriasis with IL-17, IL ...
May 22, 2024 · While IL-17 inhibitors generally have faster onset than IL-23, these findings suggest that long-term anti-IL-23 therapies appear to be linked to ...Missing: flexural | Show results with:flexural
[51]
a real-life comparison between the therapeutic effects of anti-IL-23 ...
May 15, 2024 · Patients with IP responded less to biologic agents than those with vulgar psoriasis. In the IP cohort, IL-17 inhibitors had a faster onset than IL-23 ...
[52]
Light Therapy for Psoriasis
Jan 23, 2025 · Narrow-band UVB may clear psoriasis faster and produce longer remissions; Narrow-band UVB may require fewer treatments per week. Methods of UVB ...
[53]
Psoriasis treatment: Phototherapy
The excimer laser provides a type of narrowband UVB phototherapy that can safely treat children and adults who have psoriasis on the scalp, ears, armpits ...
[54]
[PDF] Successful Treatment of Inverse Psoriasis and Psoriatic Arthritis with ...
Oct 4, 2024 · Deucravacitinib may be an effective treatment option for patients with inverse psoriasis who do not respond adequately to topical medications.
[55]
Psoriasis - ScienceDirect.com
Apr 9, 2021 · Weight gain and obesity are both risk factors and triggers, as well as a possible consequence of living with psoriasis. Innate and ...
[56]
Improving patient outcomes in psoriasis: strategies to ensure ... - NIH
In this summary, we review the causes of nonadherence, and we provide behavioral strategies in order to improve adherence and, ultimately, the outcome of ...Missing: inverse weight infections
[57]
The effect of weight on biologic therapy in patients with psoriasis
Aug 7, 2025 · Patients with psoriasis, in particular, tend to be above normal weight. Three of the 5 biologics used to treat psoriasis are fixed-dosed ...
[58]
Comparative effectiveness of combined biologic agents versus ... - NIH
Sep 18, 2024 · This study demonstrates that combined biologic agent therapy provides superior effectiveness in the treatment of plaque psoriasis, evidenced by ...
[59]
Quality of life and sexual health in patients with genital psoriasis
This study (n = 487) shows that psoriasis has a detrimental effect on quality of life and sexual health.Missing: inverse monitoring follow- ups involvement
[60]
Advancements in understanding and treating psoriasis - NIH
Apr 29, 2025 · With a prevalence of 0.1% to 0.5% in the general population, pustular psoriasis is extremely rare, accounting for less than 5% of all cases (Bu ...
[61]
Psoriasis scars: How they form, treatment, and prevention
If the itching is severe and a person scratches the area, this can result in delayed healing, hyperpigmentation, and possible scarring. Psoriasis is a chronic ...How scars form · Treatment · Prevention
[62]
Association of Psoriasis With Inflammatory Bowel Disease
Oct 24, 2018 · Patients with psoriasis had an increased risk of Crohn disease (risk ratio, 2.53; 95% CI, 1.65-3.89) and ulcerative colitis (risk ratio, 1.71; ...
[63]
How to prevent psoriasis flare-ups - Mayo Clinic Press
Aug 14, 2025 · If you are overweight or obese, try to reduce your body weight by 5% to 10%. Exercise helps reduce inflammation. Both aerobic exercise and ...Missing: inverse | Show results with:inverse
[64]
The Effect of Weight Loss in Obese Patients with Chronic Stable ...
The objective of this study was to investigate whether moderate weight loss (5–10% of body weight) increases the therapeutic response to topical treatment in ...Missing: inverse flares<|separator|>
[65]
8 ways to stop baths and showers from worsening your psoriasis
Use a gentle, moisture-rich soap or cleanser made for sensitive skin. Deodorant soaps and scrubs are too harsh, so avoid them. Wash your skin very gently ...Missing: inverse | Show results with:inverse